BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 25270999)

  • 1. Rikkunshito ameliorates cachexia associated with bleomycin-induced lung fibrosis in mice by stimulating ghrelin secretion.
    Tsubouchi H; Yanagi S; Miura A; Mogami S; Yamada C; Iizuka S; Hattori T; Nakazato M
    Nutr Res; 2014 Oct; 34(10):876-85. PubMed ID: 25270999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rikkunshito ameliorates bleomycin-induced acute lung injury in a ghrelin-independent manner.
    Tsubouchi H; Yanagi S; Miura A; Iizuka S; Mogami S; Yamada C; Hattori T; Nakazato M
    Am J Physiol Lung Cell Mol Physiol; 2014 Feb; 306(3):L233-45. PubMed ID: 24285267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice.
    Sugiyama M; Yamaki A; Furuya M; Inomata N; Minamitake Y; Ohsuye K; Kangawa K
    Regul Pept; 2012 Oct; 178(1-3):21-8. PubMed ID: 22750276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice.
    Tsubouchi H; Yanagi S; Miura A; Matsumoto N; Kangawa K; Nakazato M
    Eur J Pharmacol; 2014 Nov; 743():1-10. PubMed ID: 25257464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
    Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
    Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction.
    Yakabi K; Kurosawa S; Tamai M; Yuzurihara M; Nahata M; Ohno S; Ro S; Kato S; Aoyama T; Sakurada T; Takabayashi H; Hattori T
    Regul Pept; 2010 Apr; 161(1-3):97-105. PubMed ID: 20171995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
    Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
    J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia.
    Tseng YC; Kulp SK; Lai IL; Hsu EC; He WA; Frankhouser DE; Yan PS; Mo X; Bloomston M; Lesinski GB; Marcucci G; Guttridge DC; Bekaii-Saab T; Chen CS
    J Natl Cancer Inst; 2015 Dec; 107(12):djv274. PubMed ID: 26464423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
    Wang H; Lai YJ; Chan YL; Li TL; Wu CJ
    Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model.
    Terawaki K; Kashiwase Y; Sawada Y; Hashimoto H; Yoshimura M; Ohbuchi K; Sudo Y; Suzuki M; Miyano K; Shiraishi S; Higami Y; Yanagihara K; Hattori T; Kase Y; Ueta Y; Uezono Y
    PLoS One; 2017; 12(3):e0173113. PubMed ID: 28249026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ghrelin receptor agonist, GHRP-2, attenuates burn injury-induced MuRF-1 and MAFbx expression and muscle proteolysis in rats.
    Sheriff S; Joshi R; Friend LA; James JH; Balasubramaniam A
    Peptides; 2009 Oct; 30(10):1909-13. PubMed ID: 19577604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rikkunshito ameliorates the aging-associated decrease in ghrelin receptor reactivity via phosphodiesterase III inhibition.
    Takeda H; Muto S; Hattori T; Sadakane C; Tsuchiya K; Katsurada T; Ohkawara T; Oridate N; Asaka M
    Endocrinology; 2010 Jan; 151(1):244-52. PubMed ID: 19906817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases MuRF1 and MAFbx.
    Balasubramaniam A; Joshi R; Su C; Friend LA; Sheriff S; Kagan RJ; James JH
    Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R893-901. PubMed ID: 19211729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cachexia in the non-obese diabetic mouse is associated with CD4+ T-cell lymphopenia.
    Zhao C; Wang Z; Robertson MW; Davies JD
    Immunology; 2008 Sep; 125(1):48-58. PubMed ID: 18397274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation.
    Imazu Y; Yanagi S; Miyoshi K; Tsubouchi H; Yamashita S; Matsumoto N; Ashitani J; Kangawa K; Nakazato M
    Eur J Pharmacol; 2011 Dec; 672(1-3):153-8. PubMed ID: 21996315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of activins promotes muscle wasting and cachexia.
    Chen JL; Walton KL; Winbanks CE; Murphy KT; Thomson RE; Makanji Y; Qian H; Lynch GS; Harrison CA; Gregorevic P
    FASEB J; 2014 Apr; 28(4):1711-23. PubMed ID: 24378873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.
    Silva KA; Dong J; Dong Y; Dong Y; Schor N; Tweardy DJ; Zhang L; Mitch WE
    J Biol Chem; 2015 Apr; 290(17):11177-87. PubMed ID: 25787076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism.
    Takeda H; Sadakane C; Hattori T; Katsurada T; Ohkawara T; Nagai K; Asaka M
    Gastroenterology; 2008 Jun; 134(7):2004-13. PubMed ID: 18439428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The study on mechanism of the modified Chinese herbal compound, jianpijiedu, on a mouse model of hepatic carcinoma cachexia.
    Sun B; Luo H; Deng L; Zhang S; Chen Z
    Mol Med Rep; 2016 Oct; 14(4):3113-21. PubMed ID: 27511050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.